Supplier profile
Amgen
Every public-sector award we hold for this supplier, across Belgium, Czechia, Spain, France, the UK, Italy, Poland and UK, from 5 Feb 2008 to 20 Aug 2026.
Awards won
361
all time
Attributed value
£5.9m + €1.5bn + PLN 49k
267 shared, unvalued
Buyers
174
public bodies
Active
2008–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| The Common Services Agency (more commonly known as NHS National Services Scotland) (‘the Authority’) | 4 | £5.9m + €7.2m |
| NHS England | 60 | not attributable |
| The NHS Commissioning Board (operating under the name of NHS England) | 15 | not attributable |
| NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) | 12 | not attributable |
| CHG de Saint-Brieuc | 9 | €772k |
| CHRU de Tours | 8 | €4.3m |
| The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority") | 8 | not attributable |
| AP-HM | 6 | €11.8m |
| NHS Purchasing and Supply Agency | 6 | not attributable |
| Procurement and Logistics Service | 6 | €3.6m |
What they win
Awards
Showing 1–25 of 361 awards we hold
- Poland – Pharmaceutical products – Dostawy produktów leczniczych ↗Warmińsko-Mazurskie Centrum Chorób Płuc w Olsztynieshared awardawarded 20 Aug 2026
- Ustekinumab ↗NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)shared awardawarded 11 Aug 2026
- Ustekinumab ↗NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)shared awardawarded 7 Aug 2026
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 ↗NHS Englandshared awardawarded 6 Jul 2026
- NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026 ↗NHS Englandshared awardawarded 6 Jul 2026
- Transitional Drugs 7 ↗NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)shared awardawarded 30 Jun 2026
- Transitional Drugs 7 ↗NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)shared awardawarded 30 Jun 2026
- NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026 ↗NHS Englandawarded 15 Jun 2026
- NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026 ↗NHS Englandshared awardawarded 15 Jun 2026
- Transitional Drugs 7 ↗NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)shared awardawarded 4 Jun 2026
- Ustekinumab ↗NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)shared awardawarded 4 Jun 2026
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 ↗NHS Englandshared awardawarded 1 Jun 2026
- Belgium – Pharmaceutical products – Leveren van een terugbetaalde vorm van Bevacizumab 100 mg/4 ml en 400 mg/ 16ml voor intraveneus gebruik ↗UZ Leuvenshared awardawarded 19 Mar 2026
- Transitional Drugs 6 ↗NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)shared awardawarded 1 Mar 2026
- Transitional Drugs 6 ↗NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)shared awardawarded 29 Jan 2026
- NP49425 Generic and Biosimilar Transition Medicines ↗The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)shared awardawarded 18 Dec 2025
- Belgium – Pharmaceutical products – Farmaceutische specialiteiten op basis van ECULIZUMAB en RAVULIZUMAB ↗Healthcare Public Procurement (HeCaPP)€2.5mawarded 6 Nov 2025
- NHS National Framework for Denosumab Injection commencing 1st January 2026 ↗NHS Englandshared awardawarded 5 Nov 2025
- NP40725 Erythropoietin Stimulating Agents ↗The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)shared awardawarded 28 Oct 2025
- Project/Contract NHS National Framework for Denosumab Injection ↗NHS ENGLANDshared awardawarded 30 Sept 2025
- Romiplostim (Nplate®) ↗The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)awarded 29 Sept 2025
- NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025 ↗NHS Englandshared awardawarded 1 Jul 2025
- NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025 ↗NHS Englandshared awardawarded 1 Jul 2025
- NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 ↗NHS Englandshared awardawarded 1 Jul 2025
- NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 ↗NHS Englandshared awardawarded 25 Jun 2025
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.